For example, BHLHA15/MIST1 identified in myeloma has been reported as a plasmacytic differentiation marker and potentially controlled transcriptional network with stage-specific overexpression during plasma cells differentiation [25], [26]. This evidence concerns the gene BHLHA15 and plasma cell myeloma.